BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome

Clinical trial NCT05411900 · UNKNOWN

Trial details

NCT number: NCT05411900
Sponsor: Francesco Bono
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carpal Tunnel Syndrome Neurogenic Inflammation Pain Drug Use Neuropathic Pain

Start date: 2022-05-25
Primary completion: 2023-12-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.